SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-060239
Filing Date
2021-05-03
Accepted
2021-05-03 16:25:19
Documents
12
Period of Report
2021-04-27
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2115004d1_8k.htm   iXBRL 8-K 47050
  Complete submission text file 0001104659-21-060239.txt   224680

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vrna-20210427.xsd EX-101.SCH 3199
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrna-20210427_lab.xml EX-101.LAB 34592
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrna-20210427_pre.xml EX-101.PRE 22719
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2115004d1_8k_htm.xml XML 3702
Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Filer) CIK: 0001657312 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38067 | Film No.: 21883893
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences